Search Results - "Walker, U A"

Refine Results
  1. 1

    Increased radiographic progression of distal hand osteoarthritis occurring during biologic DMARD monotherapy for concomitant rheumatoid arthritis by Lechtenboehmer, C. A, Burkard, T, Reichenbach, S, Walker, U. A, Burden, A. M, Hügle, T

    Published in Arthritis research & therapy (26-10-2021)
    “…Abstract Objectives A considerable proportion of patients with rheumatoid arthritis (RA) also suffer from hand osteoarthritis (OA). We here assess the…”
    Get full text
    Journal Article
  2. 2

    Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database by Walker, U A, Tyndall, A, Czirják, L, Denton, C, Farge-Bancel, D, Kowal-Bielecka, O, Müller-Ladner, U, Bocelli-Tyndall, C, Matucci-Cerinic, M

    Published in Annals of the rheumatic diseases (01-06-2007)
    “…Background: Systemic sclerosis (SSc) is a multisystem autoimmune disease, which is classified into a diffuse cutaneous (dcSSc) and a limited cutaneous (lcSSc)…”
    Get full text
    Journal Article
  3. 3

    Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent? by Finckh, A, Ciurea, A, Brulhart, L, Möller, B, Walker, U A, Courvoisier, D, Kyburz, D, Dudler, J, Gabay, C

    Published in Annals of the rheumatic diseases (01-02-2010)
    “…Patients with rheumatoid arthritis (RA) with an inadequate response to TNF antagonists (aTNFs) may switch to an alternative aTNF or start treatment from a…”
    Get more information
    Journal Article
  4. 4

    Dexrazoxane prevents doxorubicin‐induced long‐term cardiotoxicity and protects myocardial mitochondria from genetic and functional lesions in rats by Lebrecht, D, Geist, A, Ketelsen, U‐P, Haberstroh, J, Setzer, B, Walker, U A

    Published in British journal of pharmacology (01-07-2007)
    “…Background and purpose: Doxorubicin causes a chronic cardiomyopathy in which reactive oxygen species (ROS) accumulate over time and are associated with genetic…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells by Distler, J H W, Allanore, Y, Avouac, J, Giacomelli, R, Guiducci, S, Moritz, F, Akhmetshina, A, Walker, U A, Gabrielli, A, Müller-Ladner, U, Tyndall, A, Matucci-Cerinic, M, Distler, O

    Published in Annals of the rheumatic diseases (01-02-2009)
    “…Systemic sclerosis (SSc) is characterised by a progressive microangiopathy that contributes significantly to the morbidity of patients with SSc. Besides…”
    Get more information
    Journal Article
  8. 8

    Rheumatic conditions in human immunodeficiency virus infection by Walker, U. A., Tyndall, A., Daikeler, T.

    Published in Rheumatology (Oxford, England) (01-07-2008)
    “…Many rheumatic diseases have been observed in HIV-infected persons. We, therefore, conducted a comprehensive literature search in order to review the…”
    Get full text
    Journal Article
  9. 9

    Gene Expression and Immunohistochemistry in Adipose Tissue of HIV Type 1–Infected Patients with Nucleoside Analogue Reverse-Transcriptase Inhibitor–Associated Lipoatrophy by Sievers, M., Walker, U. A., Sevastianova, K., Setzer, B., Wågsäter, D., Eriksson, P., Yki-Järvinen, H., Sutinen, J.

    Published in The Journal of infectious diseases (15-07-2009)
    “…BackgroundLong-term use of both zidovudine (AZT) and stavudine (d4T) is associated with lipoatrophy, but it occurs possibly through different mechanisms…”
    Get full text
    Journal Article
  10. 10

    Geographical variation of disease manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research (EUSTAR) group database by Walker, U A, Tyndall, A, Czirják, L, Denton, C P, Farge-Bancel, D, Kowal-Bielecka, O, Müller-Ladner, U, Matucci-Cerinic, M

    Published in Annals of the rheumatic diseases (01-06-2009)
    “…Systemic sclerosis (SSc) is a vasculopathy with increased tissue deposition of collagen. The aetiology is unknown. Genetic and environmental susceptibility…”
    Get more information
    Journal Article
  11. 11
  12. 12

    Erectile dysfunction in systemic sclerosis by Walker, U A, Tyndall, A, Ruszat, R

    Published in Annals of the rheumatic diseases (01-07-2009)
    “…Erectile dysfunction (ED) is observed in up to 81% of men with systemic sclerosis (SSc) and therefore should be counselled as a common complaint in this…”
    Get more information
    Journal Article
  13. 13

    Immunosuppressive treatment of chronic periaortitis: a retrospective study of 20 patients with chronic periaortitis and a review of the literature by Warnatz, K, Keskin, A G, Uhl, M, Scholz, C, Katzenwadel, A, Vaith, P, Peter, H H, Walker, U A

    Published in Annals of the rheumatic diseases (01-06-2005)
    “…Background: Retroperitoneal fibrosis (RPF) and inflammatory aneurysm of the abdominal aorta (IAAA) are regarded as two manifestations of the same disease,…”
    Get full text
    Journal Article
  14. 14

    Effect of Reducing the Dose of Stavudine on Body Composition, Bone Density, and Markers of Mitochondrial Toxicity in HIV-Infected Subjects: A Randomized, Controlled Study by McComsey, G. A., Re, V. Lo, O'Riordan, M., Walker, U. A., Lebrecht, D., Baron, E., Mounzer, K., Frank, I.

    Published in Clinical infectious diseases (15-04-2008)
    “…Background. Stavudine is widely used in developing countries. Lipoatrophy and mitochondrial toxicity have been linked to stavudine use, but it is unclear…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Tenofovir-induced osteomalacia by WANNER, D. P, TYNDALL, A, WALKER, U. A

    Published in Clinical and experimental rheumatology (01-11-2009)
    “…We present an HIV-infected woman in whom antiretroviral treatment with tenofovir disoproxil fumarate (TDF) induced severe skeletal pain, synovial effusions and…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Effects of in utero antiretroviral exposure on mitochondrial DNA levels, mitochondrial function and oxidative stress by Ross, AC, Leong, T, Avery, A, Castillo‐Duran, M, Bonilla, H, Lebrecht, D, Walker, UA, Storer, N, Labbato, D, Khaitan, A, Tomanova‐Soltys, I, McComsey, GA

    Published in HIV medicine (01-02-2012)
    “…Objectives HIV and antiretroviral (ART) exposure in utero may have deleterious effects on the infant, but uncertainty still exists. The objective of this study…”
    Get full text
    Journal Article
  19. 19

    Uridine supplementation in HIV lipoatrophy: pilot trial on safety and effect on mitochondrial indices by McComsey, G.A, O'Riordan, M, Setzer, B, Lebrecht, D, Baron, E, Walker, U.A

    Published in European journal of clinical nutrition (01-08-2008)
    “…Objectives: Uridine abrogates mitochondrial toxicities of nucleoside reverse transcriptase inhibitor in adipocyte cell culture. We aim to study the effect of…”
    Get full text
    Journal Article
  20. 20